Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CX11 in Overweight/Obese Participants
NCT07011797Phase 2Completed
- Sponsor
- CORXEL Pharmaceuticals
- Start
- Jun 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of VCT220 in obesity, sponsored by CORXEL Pharmaceuticals. Started Jun 2025; status: completed.
02
Drugs
VCT220
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07011797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07011797.